Miracle Mile Advisors’s Roivant Sciences ROIV Stock Holding History

Miracle Mile Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$503K	Sell	14,213 -31	-0.2%	-$916	0.01%	617
2026 Q1	$395K	Sell	14,244 -48	-0.3%	-$1.23K	0.01%	647
2025 Q4	$310K	Buy	14,292 +100	+0.7%	+$1.97K	﹤0.01%	697
2025 Q3	$215K	Buy	14,192 +40	+0.3%	+$495	﹤0.01%	777
2025 Q2	$159K	Buy	14,152 +1,652	+13%	+$17.9K	﹤0.01%	700
2025 Q1	$126K	Hold	12,500	–	–	﹤0.01%	622
2024 Q4	$148K	Buy	+12,500	New	+$148K	﹤0.01%	612

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Miracle Mile Advisors's ROIV Position: Q2 2026 in Review

Miracle Mile Advisors reduced its Roivant Sciences (ROIV) stake by 0.22% in Q2 2026, selling an estimated $916 and leaving 14,213 shares worth $503K. The position accounts for 0.01% of the portfolio, ranked #617.

Miracle Mile Advisors first reported a position in ROIV in Q4 2024 and has held it in 7 quarters since. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Miracle Mile Advisors held 14,213 shares of Roivant Sciences worth $503K as of Q2 2026.
Miracle Mile Advisors sold 31 Roivant Sciences shares in Q2 2026, an estimated $916.
Roivant Sciences made up 0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #617 holding.
Miracle Mile Advisors first reported a position in Roivant Sciences in Q4 2024 and has held it in 7 quarters since.
499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.